临床试验/PER-017-04

PER-017-04已完成未知

RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF PROFILACTIC HEPARIN IN PATIENTS WITH SEVERE SEPSIS AND HIGH-RISK MORTALITY DISEASE THAT IS UNDER TREATMENT WITH ALPHA DROTRECOGEN (ACTIVATED)

ELI LILLY INTERAMERICA INC.,0 个研究点目标入组 0 人开始时间: 2004年5月5日最近更新: 2023年9月4日

适应症

试验速览

阶段: 未知
状态: 已完成
发起方: ELI LILLY INTERAMERICA INC.,

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

年龄范围: 0 至 0（—）

入选标准

•Adults greater than or equal to 18 years of age
•Receiving inpatient treatment for severe sepsis
•Indicated for treatment with Drotrecogin Alfa (Activated) under approved label in the country where the patient is enrolled

排除标准

•Contraindicated for heparin treatment
•Require a higher dose of heparin than defined in the trial
•Have acute or chronic renal failure with an estimated creatinine clearance less than 30mL/min
•Weigh more than 135 kg (297 pounds)
•Are not expected to survive 28 days given their medical condition.

研究者

发起方

ELI LILLY INTERAMERICA INC.,

相似试验

RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, IN PARALLEL GROUPS, MULTICENTER, TO EVALUATE EFFICACY AND SAFETY IN TREATMENT REPEATED WITH TEGASEROD 6 MG TWICE PER DAY AND PLACEBO IN WOMEN WITH IRRITABLE BOWEL SYNDROME CO

PER-076-02OVARTIS BIOSCIENSES PERU S.A.,

DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF SINGLE ASCENDING DOSES AND THE EFFECT OF FOOD ON ORAL WCK 4873 IN HEALTHY ADULT VOLUNTEERSBacterial PneumoniaRespiratory Tract Infections10024970

NL-OMON38693Wockhardt Bio AG78

PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY OF AERUCIN® ASADJUNCT THERAPY TO ANTIBIOTICS IN THE TREATMENT OF P. AERUGINOSAPNEUMONIA-J151 Pneumonia due to PseudomonasPneumonia due to PseudomonasJ151

PER-019-18Aridis Pharmaceuticals, Inc,

RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF THE, EFFICACY, SAFETY AND TOLERABILITY OF EPA-FFA GASTRO-RESISTANT CAPSULES, IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS (FAP)FAPhereditary development of polyps in colon1001801810017991

NL-OMON55587SLA Pharma30

进行中（未招募）

A STUDY OF THE MAINTENANCE OF EFFICACY OF ETANERCEPT PLUS DMARD(S)COMPARED WITH DMARD(S) ALONE IN SUBJECTS WITH RHEUMATOID ARTHRITIS AFTER ACHIEVING AN ADEQUATE RESPONSE WITHETANERCEPT PLUS DMARD(S)Rheumatoid Arthritis

EUCTR2011-005448-87-HUPfizer Inc, 235 East 42nd Street, New York, NY 10017320